1042 T.N. LOMOVA ET AL.
pyrrol ring); ethyl vibrations, 837, 835 (g C–H methine
group); 1273 (d C–H methine group), 2869, 2963 (n
vibrations in pyrrol ring); ethyl vibrations, 833, 844, 874 (g
C–H methine group); 1263, 1274 (d C–H methine group),
2870, 2966 (n CH3); 2929 (n CH2); Pd-N -486. 1H NMR
(CDCl3): d, ppm 9.62 (d, H, meso); 8.21 (d, 8H, o-Ph),
7.71, 7.62 (d, t, 9H, m-Ph, 4H, p-Ph), 3.68, 2.52, 2.26 (q, q,
q, 16 H, CH2), 1.60, 0.65, 0.46 (t, t, t, 16 H, CH3).
1
CH3); 2929 (n CH2); Pd-N -484. H NMR (CDCl3): d,
ppm 10.12 (s, 4H, meso), 4.08 (q, 16 H, CH2), 1.92 (t,
24 H, CH3).
(2,3,7,8,12,13,17,18-octaethyl-5-phenylporphinato)-
palladium(II) PdMPOEP, 3. The synthesis was
described in [19]. UV-vis (CHCl3): lmax, nm (log e) 550
(4.59), 516 (4.34), 400 (5.50). IR (KBr): n, cm-1 benzene
ring vibrations, 710, 763 (g C–H); 1088, 1167 (d C–H);
1450, 1599 (n C=C); 3020, 3057 (n C–H); pyrrol ring
vibrations, 781 (g C–H); 1003 (C3–C4, n C–N, d C–H);
1317 (n C-N); 1465 (n C=N); 1500, 1631 (skeletal
vibrations in pyrrol ring); ethyl vibrations, 840 (g C–H
methine group); 1259, 1278 (d C–H methine group),
2870, 2963 (n CH3); 2929 (n CH2); Pd-N -486. 1H NMR
(CDCl3): d, ppm 10.10, 10.00 (d, d, 3H, meso), 8.17 (d,
2H, o-Ph), 7.63, 7.79 (t, m, 2H, m-Ph, H, p-Ph), 3.97,
2.65 (m, m, 16 H, CH2), 1.91, 1.81, 1.12, 1.00 (m, m, t,
t, 24 H, CH3).
(2,3,7,8,12,13,17,18-octaethyl-5,15-diphenylpor-
phinato)palladium(II) Pd5,15DPOEP, 4. The synthesis
was described in [19]. UV-vis (CHCl3): lmax, nm (log e)
549 (4.47), 517 (4.28), 403 (5.25). IR (KBr): n, cm-1
benzene ring vibrations, 705, 764 (g C–H); 1091, 1173 (d
C–H); 1444, 1600 (n C=C); 3020, 3056 (n C–H); pyrrol
ring vibrations, 784 (g C–H); 1003 (C3–C4, n C–N, d
C–H); 1317 (n C-N); 1450, 1465 (n C=N); 1498, 1632
(skeletal vibrations in pyrrol ring); ethyl vibrations, 842
(g C–H methine group); 1261, 1279 (d C–H methine
group), 2870, 2963 (n CH3); 2929 (n CH2); Pd-N -486.
1H NMR (CDCl3): d, ppm 9.79 (s, 2H, meso), 8.20 (d,
4H, o-Ph), 7.63, 7.79 (d, t, 4H, m-Ph, 2H, p-Ph), 3.90,
3.79, 2.54, 2.35 (q, q, q, q, 16 H, CH2), 1.79, 1.64, 0.68,
0.60 (t, t, t, t, 24 H, CH3).
(2,3,7,8,12,13,17,18-octaethyl-5,10-diphenylpor-
phinato)palladium(II) Pd5,10DPOEP, 5. The synthesis
was described in [19]. UV-vis (CHCl3): lmax, nm (log e)
561 (4.23), 527 (4.30), 412 (5.25). IR (KBr): n, cm-1
benzene ring vibrations, 705, 758 (g C–H); 1174 (d
C–H); 1443, 1599 (n C=C); 3020, 3056 (n C–H); pyrrol
ring vibrations, 780, 794 (g C–H); 1002 (C3–C4, n C–N, d
C–H); 1314 (n C-N); 1464 (n C=N); 1501, 1632 (skeletal
vibrations in pyrrol ring); ethyl vibrations, 839, 856, 880
(g C–H methine group); 1261, 1286 (d C–H methine
group), 2870, 2964 (n CH3); 2929 (n CH2); Pd-N -484.
1H NMR (CDCl3): d, ppm 9.98 (s, 2H, meso), 8.14 (d,
4H, o-Ph), 7.69, 7.62 (d, t, 4H, m-Ph, 2H, p-Ph), 3.88,
2.61 (q, q, 16 H, CH2), 1.75, 0.98 (t, t, 24 H, CH3).
(2,3,7,8,12,13.17,18-octaethyl-5,10,15-triphenylpor-
phinato)palladium(II) PdTriPOEP, 6. The synthesis
was described in [19]. UV-vis (CHCl3): lmax, nm (log e)
570 (4.38), 536 (4.38), 422 (5.32). IR (KBr): n, cm-1
benzene ring vibrations, 704, 761 (g C–H); 1089, 1173 (d
C–H); 1443, 1598 (n C=C); 3020, 3057 (n C–H); pyrrol
ring vibrations, 794 (g C–H); 1003 (C3–C4, n C–N, d
C–H); 1314 (n C-N); 1465 (n C=N); 1501, 1631 (skeletal
(2,3,7,8,12,13,17,18-octaethyl-5,10,15,20-tetraphenyl
porphinato)palladium(II) PdTetPOEP, 7. The
synthesis was described in [19]. UV-vis (CHCl3): lmax
,
nm (log e) 580 (3.92), 544 (4.21), 433 (5.27). IR (KBr):
n, cm-1 benzene ring vibrations, 702, 760 (g C–H); 1085
(d C–H); 1443, 1598 (n C=C); 3021, 3057 (n C–H);
pyrrol ring vibrations, 802 (g C–H); 1003 (C3–C4, n
C–N, d C–H); 1317, 1329 (n C-N); 1462 (n C=N); 1501,
1632 (skeletal vibrations in pyrrol ring); ethyl vibrations,
860, 879 (g C–H methine group); 1261 (d C–H methine
group), 2870, 2969 (n CH3); 2929 (n CH2); Pd-N -486.
1H NMR (CDCl3): d, ppm 8.22 (d, 8H, o-Ph, J = 4 Hz),
7.68 (m, 8H, m-Ph, 4H, p-Ph), 4.2 (d, 16 H, CH2, J = 24
Hz), 2.4 (d, 16 H, CH2, J = 23 Hz), 1.95 (d, 24 H, CH3,
J = 7 Hz), 0.5 (d, 24 H, CH3, J = 7 Hz).
(5,10,15,20-tetraphenylporphinato)chlororho-
dium(III) (Cl)RhTPP, 8. H2TPP was boiled with RhCl3
in a mole ratio of 1:5 in PhCN until the bands of H2TPP
disappeared from the electronic absorption spectra of
the reaction mixture. After the end of the reaction, the
solvent was distilled in vacuum the reaction mixture was
dissolved in chloroform and chromatographed twice on
a column packed with Al2O3 (Brockmann activity grade
II) using chloroform. UV-vis (CHCl3): lmax, nm (log e)
569 (3.79), 535 (4.33), 421 (5.31). IR (KBr): n, cm-1
phenyl substituents, 700, 749 (g C–H); 1077, 1079 (d
C–H); 1489, 1533, 1575 (n C=C); 3026, 3047 (n C–H);
pyrrole fragments, 788 (g C–H); 1014 (C3–C4, n C–N,
d C–H); 1349 (n C–N); 1436 (n C=N); 1540 (skeletal
vibrations of pyrrole ring), 2827, 2907 (n C–H); Rh–N
-457, Rh–Cl –518, 549. 1H NMR (CDCl3): d, ppm 8.93
(s, 8H, C4H2N, J = 3 Hz), 8.19 (d, 4H, o-Ph, J = 3 Hz),
8.34 (d, 4H, o′-Ph, J = 3 Hz), 7.76 (M, 8H, m-Ph, 4H,
p-Ph).
µ-oxo-bis[(oxo)(5,10,15,20-tetraphenyl21H,23H-
porphinato)]rhenium(V) [O=ReTPP]2O, 9. The
starting compound H2ReCl6 was prepared by reaction of
ReO2 with HCl under the heating. H2TPP was boiled with
H2ReCl6 in a mole ratio of 1:2 in PhOH until the bands
of H2TPP disappeared from the electronic absorption
spectrum of the reaction mixture. After the end of the
reaction, the solvent was cooled and the reaction mixture
was extracted in chloroform, multiply washed with warm
watertoremovephenolandchromatographedonacolumn
packed with Al2O3 (Brockmann activity grade II) using
chloroform. Two zones were obtained: diluted green and
concentrated green. Both zones were rechromatographed.
Green compound was chromatographed on a column
packed with silicagel using firstly benzene then mixed
solution CHCl3–C2H5OH as eluents. Three individual
zones were separated: (1) orange (Cl)ReTPP (Fig. 1,
Copyright © 2012 World Scientific Publishing Company
J. Porphyrins Phthalocyanines 2012; 16: 1042–1054